Canada’s National Advisory Committee on Immunization (NACI) on Friday recommended that Canadians aged 12-29 should take the Pfizer BioNtech Comirnaty 30 microgram dose as opposed to the Moderna Spikevax 100 microgram dose for their primary series of vaccine doses. As well, a longer interval of eight weeks between primary series doses may also lower the rare risk of Myocarditis and Pericarditis and provide a stronger immune response and higher vaccine effectiveness.
corona virus
NACI recommends longer interval between COVID-19 vaccine doses, Pfizer preferred over Moderna for Canadians aged 12-29
More Videos
-
COVID-19: Canada’s 6th wave has plateaued or is post-peak in some areas, Tam says
-
2 new Omicron sub-variants discovered as COVID-19 cases continue to decline globally: WHO
-
COVID-19: Canada’s top doctor recommends still wearing masks as BA.2 variant fuels 6th wave
-
Trucker convoy: Protesters adorn Terry Fox statue with pro-trucker slogans, Canadian flag
-
Trucker convoy: Blaring horns, cheers as hundreds descend on Parliament
-
Trucker convoy: Horns blare outside Parliament as trucker protest assembles
You are viewing an Accelerated Mobile Webpage.
View Original Article